What is the treatment for polyuria after correction of hyponatremia with 3% Sodium Chloride (NaCl)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Polyuria Post 3% NaCl for Hyponatremia

Polyuria following 3% hypertonic saline correction of hyponatremia represents an aquaresis (water diuresis) that requires immediate intervention with desmopressin to prevent overcorrection and osmotic demyelination syndrome. 1, 2

Immediate Management

Administer desmopressin 1-2 µg parenterally (IV or subcutaneously) every 6-8 hours to halt the water diuresis and prevent overcorrection. 1, 2 This medication blocks the aquaretic response that commonly emerges after hypertonic saline administration, which is the primary cause of inadvertent overcorrection. 2

  • Discontinue or reduce the 3% saline infusion immediately when polyuria develops to prevent further sodium increase 1
  • Switch to D5W (5% dextrose in water) if sodium has already been overcorrected (>8 mmol/L in 24 hours) to actively relower sodium levels 1

Monitoring Protocol

Check serum sodium every 2 hours during active polyuria until the water diuresis is controlled and sodium stabilization is confirmed. 1 This frequent monitoring is critical because:

  • Polyuria can cause sodium to rise by >12 mmol/L in 24 hours, exceeding safe correction limits 2
  • The aquaretic response is unpredictable in timing and magnitude 2
  • Osmotic demyelination syndrome risk increases dramatically with overcorrection >8 mmol/L per 24 hours 1, 3

Track urine output hourly to assess the effectiveness of desmopressin therapy and adjust dosing accordingly. 2

Target Correction Limits

The total sodium correction must not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome, regardless of the initial severity of hyponatremia. 1, 3, 4 For high-risk patients (advanced liver disease, alcoholism, malnutrition, or prior encephalopathy), limit correction to 4-6 mmol/L per day. 1

  • If sodium has already increased by 6 mmol/L in the first 6 hours, only 2 mmol/L additional correction is permitted in the remaining 18 hours 1
  • Do not attempt to normalize sodium to laboratory reference ranges—gradual correction with clinical evaluation is preferable 3

Mechanism and Rationale

The polyuria occurs because:

  • Hypertonic saline suppresses endogenous ADH secretion once plasma osmolality increases 5
  • The kidneys rapidly excrete the retained free water that accumulated during the hyponatremic state 2
  • This aquaresis is often more vigorous than anticipated, leading to overcorrection in 4.5-28% of cases without preventive measures 4, 2

Desmopressin prevents this aquaresis by providing exogenous ADH activity, allowing controlled sodium correction while maintaining the ability to administer additional hypertonic saline if needed. 2 This strategy has been shown to prevent overcorrection without adverse effects when combined with weight-based hypertonic saline dosing. 2

Common Pitfall to Avoid

Never assume polyuria will self-limit—this is the most common cause of iatrogenic overcorrection and osmotic demyelination syndrome. 1, 2 The combination of hypertonic saline plus desmopressin from the outset prevents this complication entirely, with studies showing no overcorrection when this protocol is followed. 2

If overcorrection has already occurred (sodium increased >8 mmol/L in 24 hours), immediately administer D5W and desmopressin to actively relower sodium levels, targeting a reduction to bring the total 24-hour correction to no more than 8 mmol/L from baseline. 1

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.